Less toxic and more effective cures for hepatitis C virus (HCV) infection are being developed at a rapid pace. Unfortunately, these drugs are likely to be priced out of reach for the majority people who need it around the world. It will be up to activists to strategically fight for expanding access to life saving prevention, diagnostics, treatment and care.
The Hepatitis/HIV Project of the Treatment Action Group (TAG), an activist-run AIDS/HCV/TB research and policy think tank, has been providing the latest scientific information to support activists working towards universal HCV treatment access.
Please take a few minutes and tell us how we can support your current or planned advocacy work in this critical juncture. Thank you!